Childhood Maltreatment (CM) is an important risk factor for major depressive disorder (MDD). Previous studies using emotional task-state functional magnetic resonance (task-state fMRI) found that altered brain function in prefrontal-limbic regions was the key neuropathological mechanism in adult MDD patients with experience of early-life maltreatment. However, to the best of our knowledge, there is no published study investigating brain function in MDD patients with CM experience using resting-state fMRI (rs-fMRI). In present study, we aimed to detect altered resting-state brain activity in MDD patients with CM experience, and identify significantly activated brain regions, which may provide new insights into the neural mechanism underlying the relationship between MDD and CM experience. The results showed MDD patients with CM experience were associated with increased amplitude of low-frequency fluctuation (ALFF) and altered function connection (FC) in the prefrontal cortex, when compared to MDD patients without CM. Of note, left frontal middle gyrus (LFEG) was found as a specific brain region which differentiates MDD patients with CM from patients without CM. These results suggest that rs-fMRI is a useful method in studying the correlation between MDD and CM experience and altered function of LFEG in resting-state may explain the correlation between MDD and CM experience.
7 November 2025 in Journal of Psychiatric Research
Psychotic disorders, characterized by perceptual abnormalities and cognitive decline, affect millions of people. Auditory hallucinations (AH), or the perception of non-existent sounds, are particularly taxing. While AH is often viewed as a perceptual disorder, patient distress is more closely related to cognitive factors. Research suggests that dysfunctional attentional control of auditory systems may contribute to AH development, and auditory cognitive control may be a key factor in the link between AH and functional decline. This study used magnetoencephalography (MEG) to investigate attentional control of ASSR in first-episode psychosis (FEP) within left and right primary auditory cortex (A1) at initial clinical contact and 4-12 months later. We investigated the relationships among ASSR deficits and attention-mediated sensory gain in 40 FEP and 40 matched healthy comparison subjects (HC). We measured ASSR to click trains with attention directed toward or away from the auditory stimulus at both timepoints. Results indicated that FEP patients showed reduced attentional modulation of ASSR, particularly in the right A1, and increased ASSR during passive listening in left A1, correlating with AH severity. ASSR measurements were reliable, with persistent group differences despite symptom reduction. These findings highlight the role of selective attention deficits in psychosis and suggest ASSR as a potential biomarker for temporal lobe dysfunction. Early identification of ASSR deficits could enable targeted treatments for individuals at highest risk of developing a chronic disorder.
Background: Major depressive disorder (MDD) is a prevalent chronic mental illness often treated by serotonergic pharmacotherapy and complicated by sex differences and comorbid anxiety disorders (COMs). Deficits in inhibitory control are a transdiagnostic feature of MDD and COM, though the presentation of these deficits may be impacted by competing cognitive demands, symptoms severity, sexes, and medication status. Methods: This project includes 233 participants from the Tulsa 1000 study who completed concurrent electroencephalography (EEG) and magnetic functional resonance imaging (MRI) during a stop signal task (SST). We examined how serotonergic antidepressants, biological sex, and comorbidity with an anxiety disorder uniquely relate to neural indices of inhibitory control for healthy controls (HCs), MDD, and COM using linear mixed effect models, type III ANOVAs, and optimal full propensity matching. N200, P300, and correct-related negativity (CRN) components were extracted and analyzed to index conflict monitoring, conflict resolution, and performance monitoring, respectively, in response to stop signals and their absence. Results: Our results revealed that HCs exhibited larger stop-P300 amplitudes than MDD and COM (
η
2 = 0.068); females had smaller stop-N200 amplitudes than males (
η
2 = 0.027); MDD/COM participants taking a serotonergic antidepressant exhibited less negative N200 amplitudes than those who were not (LME, B = 1.95;
η
2 = 0.044; ATE, B = 2.47). Conclusions: Our findings suggest being treated with serotonergic antidepressants are associated with neural differences in the conflict monitoring of inhibitory control in pure and comorbid depression.